vimarsana.com
Home
Live Updates
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024 : vimarsana.com
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024 : vimarsana.com
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and...
Related Keywords
United Kingdom ,
London ,
City Of ,
Grangemouth ,
Falkirk ,
Hong Kong ,
New York ,
United States ,
India ,
Mumbai ,
Maharashtra ,
Singapore ,
Nandini Piramal ,
Manufacturing Organization ,
Piramal Pharma ,
Allergan ,
Abbvie Therapeutics India Private ,
Piramal Pharma Ltd ,
Piramal Pharma Limited ,
Prnewswire Piramal Pharma Limited ,
Allergan India Pvt Ltd ,
Piramal Pharma Solutions ,
Contract Development ,
Pharma Limited ,
Third Quarter ,
Nine Months ,
Hospital Generic ,
Consumer Healthcare ,
Rights Issue ,
Inhalation Anesthesia ,
India Consumer Healthcare ,
Business Highlights ,
Hospital Generics ,
Lacto Calamine ,
Primary Number ,
Eastern Time ,
London Time ,
Singapore Time ,
Hong Kong Time ,
Diamond Pass ,
Piramal Critical Care ,
India Consumer ,
Abbvie Therapeutics India Private Limited ,